TrialDrug design, development and therapy2013

Effectiveness and safety of 0.15% ganciclovir in situ ophthalmic gel for herpes simplex keratitis - a multicenter, randomized, investigator-masked, parallel group study in Chinese patients.

Tong Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.